Extracellular Vesicles in Ocular Immunoregulation: Context-Dependent Mechanisms and Translational Evidence

Extracellular vesicles (EVs) carry immune signals between ocular cells. Their effects depend on the cell that releases them, its activation state, the recipient tissue, and the route of exposure. This narrative review examines endogenous EV signaling and administered EV preparations across the ocular surface, cornea, uvea, retina, and optic nerve. Donor corneal EVs can transfer alloantigens, and EVs from activated retinal glia can injure vascular cells. In experimental disease, selected stromal- and regulatory B-cell EVs reduce inflammation by altering antigen presentation, T-cell responses, or macrophage and microglial activity. Cargo perturbation supports some of these mechanisms, whereas many patient biofluid signatures remain associative. Two small dry-eye studies reported short-term improvements after topical treatment. Whether these benefits persist, or extend to other ocular diseases, remains unknown. Translation requires reproducible EV preparations, assays that predict activity in the target tissue, and controlled trials with longer follow-up.

Authors

Publication Details

Journal
Cells
Published
2026-11-17
DOI
https://doi.org/10.3390/cells15222096
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Extracellular Vesicles in Ocular Immunoregulation: Context-Dependent Mechanisms and Translational Evidence

Ali R. Djalilian, Elmira Jalilian, Jin Han, Melinda Alviar et al.
2 links
Cells
Extracellular vesicles in disease
article

Extracellular Vesicles in Ocular Immunoregulation: Context-Dependent Mechanisms and Translational Evidence

Ali R. Djalilian, Elmira Jalilian, Jin Han, Melinda Alviar, Sanjana Chandran, Narges Zargar Balajam, Niloofar Hashemi
article en

Abstract

Extracellular vesicles (EVs) carry immune signals between ocular cells. Their effects depend on the cell that releases them, its activation state, the recipient tissue, and the route of exposure. This narrative review examines endogenous EV signaling and administered EV preparations across the ocular surface, cornea, uvea, retina, and optic nerve. Donor corneal EVs can transfer alloantigens, and EVs from activated retinal glia can injure vascular cells. In experimental disease, selected stromal- and regulatory B-cell EVs reduce inflammation by altering antigen presentation, T-cell responses, or macrophage and microglial activity. Cargo perturbation supports some of these mechanisms, whereas many patient biofluid signatures remain associative. Two small dry-eye studies reported short-term improvements after topical treatment. Whether these benefits persist, or extend to other ocular diseases, remains unknown. Translation requires reproducible EV preparations, assays that predict activity in the target tissue, and controlled trials with longer follow-up.

CellsVol. 15(22)
Good health and well-being
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon